Mode
Text Size
Log in / Sign up
N/A N=6 Treatment

Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling

Fibrosing Alopecia · Frontal Fibrosing Alopecia · Central Centrifugal Cicatricial Alopecia

Enrolled (actual)
6
Serious AEs
0.0%
Results posted
Apr 2023
Primary outcome: Primary: Total Area Hair Count (Frontal) — 86.8 Count per cm^2

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
SOL Nova Device (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Yale University
Primary completion
Apr 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Total Area Hair Count (Frontal)
86.8
PRIMARY
Total Area Hair Count (Vertex)
117.5
SECONDARY
Hair Shaft Diameters (Frontal)
61.1
SECONDARY
Hair Shaft Diameters (Vertex)
63.5
SECONDARY
Number of Hair Follicles (Frontal)
70.3
SECONDARY
Number of Hair Follicles (Vertex)
74.0
SECONDARY
Vellus Hairs (Frontal)
1.5
SECONDARY
Vellus Hairs (Vertex)
SECONDARY
Terminal Hairs (Frontal)
85.3
SECONDARY
Terminal Hairs (Vertex)
117.5

Summary

To evaluate the efficacy microneedling via a professional tattoo machine in revitalizing hair follicles in patients with fibrosing alopecia.

Eligibility Criteria

Inclusion Criteria

  • Healthy Female
  • Diagnosing Fibrosing alopecia

Exclusion Criteria

  • Any female with hair loss for other reasons
  • Males
  • Patients with cardiac conditions or renal insufficiency
  • Pregnant patients
  • Patients containing the following who would make poor candidates for microneedling, such as skin conditions, diabetes, history of keloid formation
  • Anything additional existing comorbidities that in the opinion of the investigator may cause unnecessary risk for the patient to participate
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04342091). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search